Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.730
-0.020 (-0.53%)
At close: Aug 7, 2026, 4:00 PM EDT
3.780
+0.050 (1.34%)
Pre-market: Aug 10, 2026, 9:01 AM EDT
Pyxis Oncology Employees
Pyxis Oncology had 56 employees as of December 31, 2025. The number of employees increased by 12 or 27.27% compared to the previous year.
Employees
56
Change (1Y)
12
Growth (1Y)
27.27%
Revenue / Employee
$247,464
Profits / Employee
-$1,459,554
Market Cap
236.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 56 | 12 | 27.27% |
| Dec 31, 2024 | 44 | -6 | -12.00% |
| Sep 30, 2024 | 54 | -13 | -19.40% |
| Jun 30, 2024 | 55 | -17 | -23.61% |
| Mar 31, 2024 | 51 | -22 | -30.14% |
| Dec 31, 2023 | 50 | -25 | -33.33% |
| Sep 30, 2023 | 67 | -6 | -8.22% |
| Jun 30, 2023 | 72 | 5 | 7.46% |
| Mar 31, 2023 | 73 | 9 | 14.06% |
| Dec 31, 2022 | 75 | 19 | 33.93% |
| Sep 30, 2022 | 73 | 28 | 62.22% |
| Jun 30, 2022 | 67 | 29 | 76.32% |
| Mar 31, 2022 | 64 | 26 | 68.42% |
| Dec 31, 2021 | 56 | - | - |
| Sep 30, 2021 | 45 | - | - |
| Jun 30, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| Entrada Therapeutics | 152 |
| AC Immune | 122 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Keros Therapeutics | 87 |
| Orchestra BioMed Holdings | 86 |
| Compugen | 75 |
PYXS News
- 7 days ago - Pyxis Oncology initiated with an Overweight at Wells Fargo - TheFly
- 5 weeks ago - Pyxis Oncology announces up to $114M private placement - TheFly
- 5 weeks ago - Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones - GlobeNewsWire
- 2 months ago - Pyxis Oncology Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Pyxis Oncology Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 2 months ago - Pyxis Oncology Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Pyxis Oncologyreports Q1 EPS (37c), consensus (35c) - TheFly
- 3 months ago - Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones - GlobeNewsWire